DrugRisk Updates with Latest Case Numbers Since Januvia Lawsuits Sent to MDL Court

Share Article

DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

januvia lawsuit
Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options.

The diabetes drug safety center at DrugRisk.com is announcing new information on the site for patients taking the medications Januvia or Janumet. A federal multidistrict litigation court recently created to handle lawsuits alleging the drugs caused pancreatic cancer has issued the latest update on case volumes*.

DrugRisk is a resource center created to improve patient safety by giving those taking popular prescription drugs the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Januvia and Janumet are popular oral diabetes medications prescribed to those with type-2 diabetes, taken twice a day to lower blood sugar levels. In recent years, they have been the best-selling drugs for pharmaceutical company Merck**.

However, DrugRisk has added studies warning of a risk of Januvia cancer. In 2011, researchers from UCLA discovered subjects given Januvia had an increased risk of developing pancreatic cancer and thyroid cancer***. The American Medical Association recently advised diabetes drugs like these can double the risk of pancreatitis, a major risk factor for pancreatic cancer****.

Due to the number of patients who have filed a Januvia lawsuit alleging cancer, cases have been consolidated to a special federal multidistrict litigation court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California).

Now, the latest records from the court show 60 people have already filed a Januvia lawsuit or similar action relating to Byetta, Janumet or Victoza*.

Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.

For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*JPML 9/11/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-September-11-2013.pdf
**Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
***Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
****JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Schroeder
DrugRisk
888-415-1859
Email >
Visit website